Our Unique Ecosystem Model

Our strategy is to advance a broad array of mRNA drugs for many diseases simultaneously in order to deliver on the promise of mRNA science for patients as quickly as possible. To execute on this strategy, we have built a unique ecosystem model that enables shared learnings and parallel progress.

For each of our therapeutic areas of focus, we are advancing an internal pipeline of mRNA drugs through our wholly owned ventures and have also established partnerships with world-class therapeutic area experts in pharma and beyond. Our New Venture Labs is focused on exploring new therapeutic applications for our mRNA technology platform.

Our strategy and ecosystem enable a dynamic network effect that is advancing knowledge for the entire mRNA field.